Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response
- PMID: 10941211
- DOI: 10.1089/107632700320784
Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response
Abstract
Small diameter hydroxyethyl methacrylate-methyl methacrylate (HEMA-MMA; 75% HEMA) microcapsules containing an aggregate of viable rat hepatoma H4IIEC3 cells, after implantation into an omental pouch in Wistar rats, contained viable cells at 7 days but not 14 days. A similar transplantation of microencapsulated aggregates of human hepatoma HepG2 cells did not result in viable cells even at 7 days. The loss of viability was attributed to the tissue reaction, because both encapsulated cell types remained viable in vitro. However, it is not clear if the cells lost their viability in vivo, leading to the aggressive tissue reaction or if the latter caused the cells to starve or otherwise die. The tissue reactions to microcapsules containing rat or human hepatoma cells at day 1 was one cell layer thick and avascular. At later times, tissue reactions were comprised of three regions: macrophages, fibroblasts, and some foreign body giant cells apposed to the polymer membrane, a dense region of fibroblasts and collagen, and a region of vascularized granulation tissue. Prompt vascularization of the tissue reactions occurred after 4 days and was maintained for up to 14 days. Even at 14 days, immune cells were observed, suggesting a continued immune response toward antigens shed from the encapsulated cells.
Similar articles
-
Making microencapsulation work: conformal coating, immobilization gels and in vivo performance.J Control Release. 2000 Mar 1;65(1-2):173-86. doi: 10.1016/s0168-3659(99)00234-5. J Control Release. 2000. PMID: 10699279
-
Viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated PC12 cells after omental pouch implantation within agarose gels.Tissue Eng. 2003 Oct;9(5):1023-36. doi: 10.1089/107632703322495664. Tissue Eng. 2003. PMID: 14633386
-
Morphological assessment of hepatoma cells (HepG2) microencapsulated in a HEMA-MMA copolymer with and without Matrigel.J Biomed Mater Res. 1992 Nov;26(11):1401-18. doi: 10.1002/jbm.820261102. J Biomed Mater Res. 1992. PMID: 1332972
-
Vascularization and improved in vivo survival of VEGF-secreting cells microencapsulated in HEMA-MMA.Tissue Eng. 2007 Sep;13(9):2259-69. doi: 10.1089/ten.2006.0284. Tissue Eng. 2007. PMID: 17523877
-
Microencapsulated human hepatoma (HepG2) cells: in vitro growth and protein release.J Biomed Mater Res. 1993 Oct;27(10):1213-24. doi: 10.1002/jbm.820271002. J Biomed Mater Res. 1993. PMID: 8245036
Cited by
-
Profiles of carbohydrate ligands associated with adsorbed proteins on self-assembled monolayers of defined chemistries.J Biomed Mater Res A. 2010 Mar 15;92(4):1329-42. doi: 10.1002/jbm.a.32457. J Biomed Mater Res A. 2010. PMID: 19353560 Free PMC article.
-
Biomaterials direct functional B cell response in a material-specific manner.Sci Adv. 2021 Dec 3;7(49):eabj5830. doi: 10.1126/sciadv.abj5830. Epub 2021 Dec 1. Sci Adv. 2021. PMID: 34851674 Free PMC article.
-
Challenges and emerging technologies in the immunoisolation of cells and tissues.Adv Drug Deliv Rev. 2008 Jan 14;60(2):124-45. doi: 10.1016/j.addr.2007.08.034. Epub 2007 Oct 11. Adv Drug Deliv Rev. 2008. PMID: 18022728 Free PMC article. Review.
-
Cell microencapsulation with synthetic polymers.J Biomed Mater Res A. 2015 Feb;103(2):846-59. doi: 10.1002/jbm.a.35205. Epub 2014 Aug 18. J Biomed Mater Res A. 2015. PMID: 24771675 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources